Skip to main content
Side-by-Side Comparison

CJC-1295 vs Sermorelin

Dosing, half-life, mechanism, benefits, and safety — side by side.

CJC-1295

Research

Long-acting GHRH analog for sustained growth hormone elevation

Half-Life

~30 min (no DAC) / 6-8 days (DAC)

Route

SC

Dose

100-300 mcg (no DAC) / 2 mg (DAC) 1-2x/day (no DAC) or 1-2x/week (DAC)

MW

3647.19 Da

Full CJC-1295 research guide →

Sermorelin

Research

GHRH analog stimulating natural growth hormone production

Half-Life

10-20 minutes

Route

SC

Dose

200-500 mcg Daily

MW

3357.88 Da

Full Sermorelin research guide →

Quick Reference

CJC-1295Sermorelin
CategoryN/AN/A
RouteSCSC
Typical Dose100-300 mcg (no DAC) / 2 mg (DAC) 1-2x/day (no DAC) or 1-2x/week (DAC)200-500 mcg Daily
FrequencyN/ADaily
FDA ApprovedNoNo
WADA StatusBannedBanned

Pharmacokinetics

CJC-1295Sermorelin
Half-Life~30 min (no DAC) / 6-8 days (DAC)10-20 minutes
Research StatusResearch compound - GHRH analogFDA approved
CAS Number863288-34-086168-78-7

Molecular

CJC-1295Sermorelin
Molecular Weight3647.193357.88
Molecular FormulaC165H269N47O46C149H246N44O42S
Sequence Length18 aa216 aa
MechanismGHRH analogue with extended half-lifeGHRH analogue for pulsatile GH release

Key Benefits

CJC-1295Sermorelin
BenefitsFat loss support; Growth hormone boost; Lean muscle mass; Enhanced recovery; Improved sleep quality; Anti-aging effects; GH/IGF-1 Elevation: 2-10 fold GH increase for 6+ days; 45% IGF-1 increase; Extended Half-life: 5.8-8.1 days vs minutes for native GHRHNatural GH stimulation; Improved sleep; Recovery enhancement; Anti-aging effects; Body composition; FDA approved; Increases natural GH production; Improves sleep

Safety & Warnings

CJC-1295Sermorelin
Safety NoteResearch compound only. Limited human safety data available.FDA approved for growth hormone deficiency. Well-established safety profile.
Side EffectsInjection site reactions; WADA Prohibited; Severe/Fatal side effect; Flushing; Water retention; Joint pain; Hunger increase; Rare dizziness or prolactin riseInteraction; Interaction; Antibody formation; Dizziness, urticaria; Injection site reactions; Headache; Flushing; Generally well-tolerated
Athlete Warning🛑 WADA BANNED - Prohibited in competitive sports as growth hormone releasing agent🛑 WADA BANNED - Prohibited in competitive sports as growth hormone releasing agent

Which should you choose?

CJC-1295 has a longer half-life (~~30 min (no DAC) / 6-8 days (DAC)) than Sermorelin (~10-20 minutes), which can mean less frequent dosing.

CJC-1295 vs Sermorelin — FAQ

Which has a longer half-life: CJC-1295 or Sermorelin?

CJC-1295 has a half-life of ~~30 min (no DAC) / 6-8 days (DAC) while Sermorelin has a half-life of ~10-20 minutes. A longer half-life generally means less frequent dosing and more stable levels.

Can I stack CJC-1295 and Sermorelin together?

Whether CJC-1295 and Sermorelin can be stacked depends on their mechanisms and receptor targets. Use the stack compatibility checker to analyze synergies and conflicts before combining any peptides.

Which is better: CJC-1295 or Sermorelin?

There is no universal "better" peptide — it depends on your goal. CJC-1295 is GHRH analogue with extended half-life. Sermorelin is GHRH analogue for pulsatile GH release. Choose based on your primary goal and research profile.